Reply: To PMID 22562533

Comment

Albert J Czaja. Dig Dis Sci. 2013 May.

. 2013 May;58(5):1441-2.

No abstract available

Comment on

Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation.
Czaja AJ. Czaja AJ. Dig Dis Sci. 2012 Sep;57(9):2248-66. doi: 10.1007/s10620-012-2179-3. Epub 2012 May 6. Dig Dis Sci. 2012. PMID: 22562533 Review.
May oxidative stress contribute to autoimmune hepatitis pathogenesis, and can antioxidants be of value as adjuvant therapy for refractory patients?
Moreno-Otero R. Moreno-Otero R. Dig Dis Sci. 2013 May;58(5):1440-1. doi: 10.1007/s10620-013-2622-0. Epub 2013 Mar 17. Dig Dis Sci. 2013. PMID: 23504353 No abstract available.

May oxidative stress contribute to autoimmune hepatitis pathogenesis, and can antioxidants be of value as adjuvant therapy for refractory patients?
Moreno-Otero R. Moreno-Otero R. Dig Dis Sci. 2013 May;58(5):1440-1. doi: 10.1007/s10620-013-2622-0. Epub 2013 Mar 17. Dig Dis Sci. 2013. PMID: 23504353 No abstract available.
De novo autoimmune hepatitis following liver transplantation: a case report.
Di Cocco P, Barletta A, Clemente K, D'Angelo M, Greco S, Mazzotta C, Orlando G, Rizza V, Famulari A, Grimaldi A, Pisani F. Di Cocco P, et al. Transplant Proc. 2008 Jul-Aug;40(6):2073-4. doi: 10.1016/j.transproceed.2008.05.042. Transplant Proc. 2008. PMID: 18675134
Recurrent autoimmune hepatitis after liver transplantation: a disease continuum or a fresh start?
Czaja AJ. Czaja AJ. Liver Transpl. 2009 Oct;15(10):1169-71. doi: 10.1002/lt.21809. Liver Transpl. 2009. PMID: 19790163 No abstract available.
Noninvasive markers in the assessment and management of autoimmune liver diseases.
Grunwald D, Kothari D, Malik R. Grunwald D, et al. Eur J Gastroenterol Hepatol. 2014 Oct;26(10):1065-72. doi: 10.1097/MEG.0000000000000176. Eur J Gastroenterol Hepatol. 2014. PMID: 25144494 Review.
Autoimmune hepatitis.
Geller SA. Geller SA. Pathology (Phila). 1994;3(1):57-76. Pathology (Phila). 1994. PMID: 9420892 Review.